Canopus BioPharma Selected To Present Its Drug Candidate For HIV/AIDS Treatment At The Global Summit On AIDS And The Church

Canopus BioPharma, Inc. (OTCPK:CBIA), a biotechnology company developing pharmaceutical products and assay methods for patients suffering from infectious disease, radiation sickness, cancer, and addiction, announced today that its President Len Rothstein presented at the Global Summit on AIDS and the Church, which was held from November 28-30, 2007, in Lake Forest, California, as part of the Treatment Horizons Workshop. Mr. [click link for full article]

More: continued here

Filed under: HIV / AIDS on December 6th, 2007